Yusha Xiao

1.2k total citations
24 papers, 838 citations indexed

About

Yusha Xiao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yusha Xiao has authored 24 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yusha Xiao's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yusha Xiao is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yusha Xiao collaborates with scholars based in China, United States and France. Yusha Xiao's co-authors include Quanyan Liu, Zhisu Liu, Tao Guo, Lei Chang, Kang Yang, Haolong Qi, Yufeng Yuan, Baiyang Chen, Daoming Zhu and Cuicui Li and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Cell Death and Differentiation.

In The Last Decade

Yusha Xiao

23 papers receiving 830 citations

Peers

Yusha Xiao

PRM

ONCOL

Shangzhi Xie China

Donghai Jiang China

Chunyu Hou China

Liangqi Cao China

Dimas Carolina Belisario Italy

Tianqiang Song China

Jinlu Ma China

Chun-Ying Qu China

Anna Pastò Italy

Yan Hu China

Shangzhi Xie China

Yusha Xiao

565 ×1.2

361 ×1.1

178 ×1.0

55 ×0.4

PRM

188 ×2.1

ONCOL

Citations per year, relative to Yusha Xiao Yusha Xiao (= 1×) peers Shangzhi Xie

Countries citing papers authored by Yusha Xiao

Since Specialization

Citations

This map shows the geographic impact of Yusha Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusha Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusha Xiao more than expected).

Fields of papers citing papers by Yusha Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusha Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusha Xiao. The network helps show where Yusha Xiao may publish in the future.

Co-authorship network of co-authors of Yusha Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yusha Xiao. A scholar is included among the top collaborators of Yusha Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusha Xiao. Yusha Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Yusha, et al.. (2023). Comparative genetic and epigenetic of the Sphagneticola trilobata (L.) Pruski from different regions in China. BMC Plant Biology. 23(1). 289–289. 1 indexed citations

Xiao, Yusha, Lihua Ni, Hongjie Shi, et al.. (2023). SAA1 deficiency alleviates cardiac remodeling by inhibiting NF‐κB /p38/ JNK and TGFβ /Smad pathways. The FASEB Journal. 37(5). e22911–e22911. 9 indexed citations

Song, Huajie, et al.. (2023). PLCL1 suppresses tumour progression by regulating AMPK/mTOR-mediated autophagy in renal cell carcinoma. Aging. 15(19). 10407–10427. 7 indexed citations

Xiao, Yusha, et al.. (2021). Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism. International Journal of Biological Sciences. 18(1). 82–95. 23 indexed citations

Chen, Baiyang, Yusha Xiao, Pengpeng Liu, et al.. (2021). Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway. Cancer Letters. 513. 75–89. 31 indexed citations

Ma, Weijie, Daoming Zhu, Jinghua Li, et al.. (2020). Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics. 10(3). 1281–1295. 185 indexed citations

Guo, Tao, Gong Cheng, Ping Wu, et al.. (2020). LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles. Cell Death and Differentiation. 27(7). 2191–2205. 49 indexed citations

Chen, Baiyang, Yukun He, Yusha Xiao, et al.. (2020). Heated fennel therapy promotes the recovery of gastrointestinal function in patients after complex abdominal surgery: A single-center prospective randomized controlled trial in China. Surgery. 168(5). 793–799. 6 indexed citations

Gu, Yang, Jun Li, Deliang Guo, et al.. (2020). Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Frontiers in Genetics. 11. 153–153. 36 indexed citations

10.

Yang, Kang, et al.. (2020). Mindin deficiency alleviates renal fibrosis through inhibiting NF‐κB and TGF‐β/Smad pathways. Journal of Cellular and Molecular Medicine. 24(10). 5740–5750. 12 indexed citations

11.

Xiao, Yusha, et al.. (2019). Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms. Journal of Experimental & Clinical Cancer Research. 38(1). 458–458. 55 indexed citations

12.

Xiao, Yusha, Baiyang Chen, Kang Yang, et al.. (2019). Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Experimental Cell Research. 383(2). 111542–111542. 9 indexed citations

13.

Yang, Kang, Yusha Xiao, Tao Xu, et al.. (2019). Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis. Cancer Gene Therapy. 27(7-8). 607–618. 20 indexed citations

14.

Qin, Xian, Changsheng Li, Tao Guo, et al.. (2017). Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway. Journal of Experimental & Clinical Cancer Research. 36(1). 148–148. 54 indexed citations

15.

Chang, Lei, Haolong Qi, Yusha Xiao, et al.. (2016). Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor. Growth Hormone & IGF Research. 29. 11–20. 11 indexed citations

16.

Guo, Tao, Yusha Xiao, Zhisu Liu, & Quanyan Liu. (2016). The impact of intraoperative vascular occlusion during liver surgery on postoperative peak ALT levels: A systematic review and meta-analysis. International Journal of Surgery. 27. 99–104. 7 indexed citations

17.

Chang, Lei, Yufeng Yuan, Cuicui Li, et al.. (2016). Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Letters. 383(2). 183–194. 129 indexed citations

18.

Guo, Tao, et al.. (2015). S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis. PLoS ONE. 10(3). e0122124–e0122124. 53 indexed citations

19.

Qi, Haolong, Changsheng Li, Yusha Xiao, et al.. (2015). The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma. Tumor Biology. 37(1). 1079–1089. 33 indexed citations

20.

Li, Ting, Tao Guo, Haolong Qi, et al.. (2015). The Plasma S-adenosylmethionine Level is Associated With the Severity of Hepatitis B-Related Liver Disease. Medicine. 94(4). e489–e489. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact